Kyongbo Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 0.58%

Kyongbo Pharmaceutical Co Ltd (214390) has an Asset Resilience Ratio of 0.58% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Kyongbo Pharmaceutical Co Ltd for a breakdown of total debt and financial obligations.

Liquid Assets

₩1.83 Billion

≈ $1.24 Million USD Cash + Short-term Investments

Total Assets

₩316.49 Billion

≈ $214.48 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2024)

This chart shows how Kyongbo Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See Kyongbo Pharmaceutical Co Ltd (214390) net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Kyongbo Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 214390 company net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩1.83 Billion	0.58%
Total Liquid Assets	₩1.83 Billion	0.58%

Asset Resilience Insights

Limited Liquidity: Kyongbo Pharmaceutical Co Ltd maintains only 0.58% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Kyongbo Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Kyongbo Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	3.73%
Yuhan Corp. KO:000100	Drug Manufacturers - Specialty & Generic	0.99%
Tasly Pharmaceutical Group Co Ltd SHG:600535	Drug Manufacturers - Specialty & Generic	9.09%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.02%
Zhejiang Jiuzhou Pharm Co Ltd SHG:603456	Drug Manufacturers - Specialty & Generic	0.01%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%

Annual Asset Resilience Ratio for Kyongbo Pharmaceutical Co Ltd (2017–2024)

The table below shows the annual Asset Resilience Ratio data for Kyongbo Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.70%	₩2.00 Billion ≈ $1.36 Million	₩283.89 Billion ≈ $192.39 Million	+0.38pp
2023-12-31	0.33%	₩870.00 Million ≈ $589.59K	₩266.31 Billion ≈ $180.47 Million	-0.03pp
2022-12-31	0.36%	₩870.00 Million ≈ $589.59K	₩240.54 Billion ≈ $163.01 Million	+0.85pp
2021-12-31	-0.49%	₩-1.16 Billion ≈ $-786.85K	₩236.98 Billion ≈ $160.60 Million	-4.26pp
2020-12-31	3.77%	₩9.54 Billion ≈ $6.47 Million	₩253.24 Billion ≈ $171.62 Million	+4.21pp
2019-12-31	-0.44%	₩-1.05 Billion ≈ $-713.64K	₩237.82 Billion ≈ $161.17 Million	+0.27pp
2018-12-31	-0.71%	₩-1.58 Billion ≈ $-1.07 Million	₩221.62 Billion ≈ $150.19 Million	-0.07pp
2017-12-31	-0.64%	₩-1.32 Billion ≈ $-895.45K	₩204.87 Billion ≈ $138.84 Million	--

pp = percentage points

About Kyongbo Pharmaceutical Co Ltd

KO:214390 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$108.22 Million

₩159.70 Billion KRW

Market Cap Rank

#18883 Global

#992 in Korea

Share Price

₩6680.00

Change (1 day)

-1.76%

52-Week Range

₩4765.00 - ₩8550.00

All Time High

₩19100.23